Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients - PubMed (original) (raw)
. 1994 Nov;108(5):813-21; discussion 821-2.
Affiliations
- PMID: 7967662
Free article
Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients
J H Peters et al. J Thorac Cardiovasc Surg. 1994 Nov.
Free article
Abstract
The value of endoscopic surveillance of Barrett's esophagus and the appropriate management of high-grade dysplasia remain unclear. Seventeen patients who were referred from endoscopic surveillance programs for management of high-grade dysplasia or adenocarcinoma developing in Barrett's esophagus were compared with 35 patients who had a newly recognized Barrett's adenocarcinoma, who had not been in a surveillance program. The referral diagnosis in the surveyed group was adenocarcinoma in six and high-grade dysplasia in 11. After repeat endoscopy with aggressive biopsy, two additional patients with adenocarcinoma were identified. Of the nine patients who underwent esophagectomy for high-grade dysplasia, five had invasive adenocarcinoma in the esophagectomy specimen, which had been missed before the operation, despite the fact that the median number of biopsy specimens obtained per 2 cm of Barrett's mucosa was 7.8 (range 1.5 to 15.0). Overall, 13 patients in the surveyed group had adenocarcinoma, 12 staged early and one staged intermediate by the WNM classification. Surveyed patients were operated on at an earlier stage than the nonsurveyed patients (10 early, 14 intermediate, and 11 late stage tumors; chi 2 = 15.6, p < 0.01). Despite the presence of adenocarcinoma in 13 of the 17 surveyed patients, their survival was significantly better than that of the nonsurveyed group (chi 2 = 5.8, p < 0.05). Patients referred from surveillance programs for Barrett's esophagus have a better outcome and earlier stage tumors than nonsurveyed patients. Inasmuch as multiple biopsy procedures do not exclude the presence of adenocarcinoma, continued surveillance of high-grade dysplasia is dangerous and potentially destructive to surveillance efforts.
Similar articles
- Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus.
Incarbone R, Bonavina L, Saino G, Bona D, Peracchia A. Incarbone R, et al. Surg Endosc. 2002 Feb;16(2):263-6. doi: 10.1007/s00464-001-8161-3. Epub 2001 Nov 16. Surg Endosc. 2002. PMID: 11967675 - [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
Incarbone R, Bonavina L, Bassi F, Peracchia A. Incarbone R, et al. Chir Ital. 2002 Sep-Oct;54(5):591-6. Chir Ital. 2002. PMID: 12469454 Italian. - Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
Clark GW, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, Hinder RA, Bremner CG, DeMeester TR. Clark GW, et al. Arch Surg. 1994 Jun;129(6):609-14. doi: 10.1001/archsurg.1994.01420300051007. Arch Surg. 1994. PMID: 8204035 - Treatment of Barrett's esophagus with high-grade dysplasia.
McAllaster JD, Buckles D, Al-Kasspooles M. McAllaster JD, et al. Expert Rev Anticancer Ther. 2009 Mar;9(3):303-16. doi: 10.1586/14737140.9.3.303. Expert Rev Anticancer Ther. 2009. PMID: 19275509 Review. - [Screening for adenocarcinoma in Barrett's esophagus: yes or no, when and how?].
Sostres C, Lacarta P, Lanas A. Sostres C, et al. Gastroenterol Hepatol. 2013 Oct;36(8):520-6. doi: 10.1016/j.gastrohep.2012.11.010. Epub 2013 Mar 1. Gastroenterol Hepatol. 2013. PMID: 23453559 Review. Spanish.
Cited by
- Screening for Barrett's Esophagus.
Atkinson M, Chak A. Atkinson M, et al. Tech Gastrointest Endosc. 2010 Apr 1;12(2):62-66. doi: 10.1016/j.tgie.2010.02.009. Tech Gastrointest Endosc. 2010. PMID: 20657789 Free PMC article. - Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer.
Barr H. Barr H. Gut. 2003 Jan;52(1):14-5. doi: 10.1136/gut.52.1.14. Gut. 2003. PMID: 12477751 Free PMC article. No abstract available. - The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia.
Edwards MJ, Gable DR, Lentsch AB, Richardson JD. Edwards MJ, et al. Ann Surg. 1996 May;223(5):585-9; discussion 589-91. doi: 10.1097/00000658-199605000-00014. Ann Surg. 1996. PMID: 8651749 Free PMC article. - Barrett's esophagus: A review of diagnostic criteria, clinical surveillance practices and new developments.
Booth CL, Thompson KS. Booth CL, et al. J Gastrointest Oncol. 2012 Sep;3(3):232-42. doi: 10.3978/j.issn.2078-6891.2012.028. J Gastrointest Oncol. 2012. PMID: 22943014 Free PMC article. - Barrett's esophagus: a surgical disease.
Patti MG, Arcerito M, Feo CV, Worth S, De Pinto M, Gibbs VC, Gantert W, Tyrrell D, Ferrell LF, Way LW. Patti MG, et al. J Gastrointest Surg. 1999 Jul-Aug;3(4):397-403; discussion 403-4. doi: 10.1016/s1091-255x(99)80056-0. J Gastrointest Surg. 1999. PMID: 10482692
MeSH terms
LinkOut - more resources
Full Text Sources
Medical